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1.1. Background
For more than the last 40 years, the relationship between
physical activity and cognitive functioning has been studied
extensively in observational studies. These studies show a
positive relationship between physical activity and cognitive
functioning in healthy elderly individuals [1,2]. A physically
active lifestyle in early and midlife seems to protect
against cognitive decline later in late life [3,4]. However, a
recent study failed to detect improvements in cognitive
functioning in sedentary healthy elderly individuals after a
physical activity program [5]. Themethodology in that study
was criticized for short exercise sessions with low dose in-
tensity and being unsupervised [6]. Randomized controlled
trials (RCTs) showed that aerobic exercise improves cogni-
tive functioning, particularly executive functioning, in
healthy elderly individuals [7,8]. Aerobic exercise in
healthy elderly individuals was associated with larger
brain volume in gray matter (GM) regions, in particular
the anterior hippocampus and white matter (WM) regions
[9,10]. However, RCTs of aerobic exercise in patients
with cognitive impairment and dementia are limited and
show mixed results, which may be partly because of
methodological issues [11,12].
The biological mechanisms underlying the apparent
positive effects of physical activity on cognitive functioning
are still poorly understood. Reviews that summarize the
findings of studies investigating the relationship between
physical activity and cognition stress the need to perform
RCTs with measures of underlying mechanisms as primary
outcome measure [11,13]. Understanding the mechanism
is essential before implementing physical activity as
preventive therapy [13,14].
Earlier studies have tried to explain the beneficial effect
of physical activity on cognition. Some theories of the
potential mechanism include reduction of inflammation,
increase in growth factors and neurotransmitters, and
neurogenesis in addition to reduction in chronic (cardio-
vascular) diseases and improvement in vascular health
[13]. Mouse models have demonstrated a beneficial effect
of aerobic exercise on stroke prevention [13,15,16].
Furthermore, studies with rats suggest that the effect of
aerobic exercise on cognitive functioning may act
through an increased perfusion of the brain [17]. The
results of an early observational study in healthy elderly
individuals support the relationship among physical activ-
ity, cerebral blood flow (CBF), and cognition [18]. In
this latter study, retirees who were physically inactive
showed significant declines in CBF for more than 4 years
and also performed worse on cognitive tests at the end of
the study in comparison with retirees who were physicallyactive. This suggests that the link between physical activity
and cognition may be mediated, at least in part, by an
improvement in CBF.
Vascular cognitive impairment (VCI) is one of the most
important causes of cognitive impairment and dementia
[19]. VCI is defined as cognitive impairment associated
with and thought to be because of cerebrovascular disease.
In addition to cognitive decline, patients with VCI
frequently suffer from behavioral and psychological symp-
toms. As a consequence, VCI has a tremendously negative
impact on daily functioning and quality of life for patients
and their families. Cognitive impairment in VCI may be
partly mediated by progressive cerebrovascular damage re-
sulting in a decline in CBF [20]. Treatments that could
improve cerebral hemodynamics may also improve cogni-
tive functioning in patients with VCI [21,22]. However,
currently secondary prevention by modifying vascular risk
factors and, if indicated, prescribing antithrombotic agents
is the only available evidence-based treatment for patients
with VCI. Despite the increasing prevalence of cerebrovas-
cular disease, few intervention studies focus on this specific
group of patients. Aerobic exercise may be a promising
approach to delay, minimize, or even prevent the progression
of VCI [23,24].
Here, we describe the design of exercise on cerebral
perfusion in patients with vascular cognitive impairment
(ExCersion-VCI), which aims to study the effect of an aero-
bic exercise program of 14 weeks on CBF in 80 patients with
VCI, in a proof-of-concept single-blind RCT.
Our primary objective is to assess whether aerobic exer-
cise leads to increased CBF in patients with VCI, determined
by arterial spin labeling magnetic resonance imaging (ASL-
MRI). Our secondary objectives are to assess the effect of
aerobic exercise on (1) cognitive and physical functioning,
(2) blood biomarkers, (3) brain function and structure, and
(4) (instrumental) activities of daily living and quality of
life. In a separate add-on study, we assess the effect of aero-
bic exercise on cerebral autoregulation efficacy (CA) and ce-
rebral vasomotor reactivity (CVMR) as major physiological
pathways involved in controlling CBF.2. Methods
The ExCersion-VCI is a multicenter single-blind RCT.
ExCersion-VCI is part of the Heart-Brain Connection, a
national multidisciplinary collaborative network of six
Dutch university medical centers, funded by CardioVascu-
lair Onderzoek Nederland [25]. The medial ethics commit-
tee/institutional review board of the VU University
Medical Center (VUmc) in Amsterdam approved the study.
Dutch Trial Register: NTR5668 (http://www.trialregister.nl/
trialreg/admin/rctview.asp?TC55668).
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Participants are patients with VCI without dementia. We
include 80 participants whomeet the inclusion and exclusion
criteria as given in Table 1.2.2. Procedures
Participants undergo screening, baseline and postassess-
ment (Fig. 1 and Table 2).
Eligible patients are recruited through the outpatient mem-
ory clinic of the VUmc and treating physicians in the Univer-
sity Medical Center Utrecht (UMCU). Patients eligible for
participation are providedwith study information and are given
at least a week for consideration. When interested in participa-
tion, the participant provides written informed consent before
performance of any study-related procedure. The aim of the
screening visit is to assess possible safety concerns before
measuring physical fitness. This visit includes the Physical Ac-
tivity Readiness Questionnaire, a screening tool for readiness
to perform exercise [26]. When study participation is consid-
ered safe, the baseline assessment is scheduled. Baseline and
postassessment are performed with a maximum of 14 days
before the first and 14 days after the last exercise session.
We aim to schedule all assessments in one day, and we attempt
to schedule baseline and postassessments on the same time of
the day to limit diurnal influences on outcome parameters.2.3. Randomization and blinding
After baseline assessment, participants are allocated to
either the aerobic exercise program or to the control group
using the so-called minimization approach, to ensure bal-
ance between the intervention and control group [27]. Mini-
mization is a method of adaptive stratified sampling; patients
are sequentially assigned by attempting to minimize the total
imbalance between both groups using prognostic factorsTable 1
Inclusion and exclusion criteria
Inclusion criteria
 Age 50 years
 Cognitive complaints
 Clinical Dementia Rating score 0.5 and Mini-Mental State
Examination 22
 Presence of a primary caregiver
 On brain MR, moderate-to-severe white matter lesions (Fazekas
scale . 1) and/or (lacunar) infarct(s) and/or intracerebral (micro-)
hemorrhage(s)
OR
On brain MR, mild white matter lesions (Fazekas scale 5 1) and at
least two of the following vascular risk factors: hypertension,
hypercholesterolemia, diabetes mellitus, obesity, smoking, or
clinically manifest vascular disease (last event. 6mo ago), clinically
manifest vascular disease comprises peripheral arterial disease,
myocardial infarction, percutaneous coronary intervention/coronary
artery bypass graft, and/or stroke[28]. Minimization is performed using the Minim software
with a 1:1 allocation ratio and equal weighting for four mini-
mization factors: disease severity (Clinical Dementia Rating
0 vs. 0.5), age (,65 vs..65 years), gender, and center [29].
An independent researcher blinded for participants’ identity
performs the randomization. Outcome assessors are blinded
for group allocation, but it is not possible to blind partici-
pants and personnel supervising the interventions. Before
postassessment, participants are instructed not to disclose
their group allocation to the outcome assessor.
3. Intervention
Participants are randomized to either the aerobic exercise
group or to the control group.
3.1. Aerobic exercise group
The aerobic exercise program is designed to improve
cardiorespiratory fitness. Participants are provided with a
bicycle ergometer (Kettler Ergometer E7, Ense, Deutsch-
land) at home to perform exercise sessions. The total exer-
cise program lasts 14 weeks with a frequency of three times
per week. In total, there are 42 exercise sessions; each ses-
sion consists of warming up (10 minutes), core activity
(25 minutes), and cooling down (10 minutes). The core ac-
tivity is interval training, based on the 4! 4 minutes aer-
obic interval training model (Fig. 2). This type of training
has been used in several studies with healthy subjects and
various cardiac patients [30]. The interval training contains
four cycles of different exercise intensities. Each cycle lasts
7 minutes: 4 minutes of high intensity exercise (85%–95%
heart rate peak [HRpeak]), followed by 3 minutes of low-
to-moderate intensity exercise (60%–70% HRpeak). The
intensity of each cycle is individualized for participants
using their individual activity level (HRpeak), assessed dur-
ing a maximal cardiopulmonary exercise test. The HR isExclusion criteria
 Diagnosis of dementia
 Contraindication for MRI or unable to undergoMRI protocol because
of a physical condition
 Participation in aerobic exercise program (moderate-to-hard
intensity)  twice weekly on a regular basis
 Major neurologic, psychiatric, cardiac, musculoskeletal, or other
medical disease that affects cognition and/or mobility and constitutes
a contraindication to perform aerobic exercise training
 Participation in another clinical trial
Aerobic exercise group
n = 40 
Control group
n = 40 
n = 80 Randomization
Week 0 
Baseline: 
outcome
measures
Screening 
visit Week 14 
Post- 
assessment: 
outcome 
measures 
Primary outcome measure:  
Cerebral blood flow (ASL-MRI) 
Secondary outcome measures: 
Cognitive functioning 
(instrumental) Activities of daily living 
Quality of life 
Physical fitness / physical activity 
Blood biomarkers 
Brain structure 
Cerebral autoregulation / cerebral 
vasomotor reactivity 
Fig. 1. Schematic overview of study design.
Table 2
Overview of assessments per visit
Measurement Screening Baseline Postassessment
Demographic characteristics X
MMSE X X
Medical history X
Vascular risk factors X
PAR-Q X
Weight and height X X
Waist and hip circumference X X
12-Lead ECG X X
Transthoracic
echocardiography*
X
Blood pressure X X X
Neuropsychological
assessment
X X
Brain MRI X X
Cardiac MRI X
Physical fitness (6MWT,
VO2max)
X X
Physical activity (activity
monitor)
X X
Blood samples X X
General functioning (DAD,
CDR, iADL)
X X
Neuropsychiatric measures X X
Quality of life X X
Hemodynamic parametersy X X
Cerebral parametersy X X
Respiratory parametersy X X
Abbreviations: CDR, Clinical Dementia Rating; DAD, disability assess-
ment of dementia; ECG, electrocardiography; iADL, instrumental activities
in daily life; MMSE, Mini-Mental State Examination; MRI, magnetic reso-
nance imaging; 6MWT, six-minute walk test; PAR-Q, Physical Activity
Readiness Questionnaire; VO2max, maximum oxygen consumption.
*Transthoracic echocardiography is only performed in Amsterdam.
yThese parameters are part of the add-on study.
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pant exercises with the intended intensity.
A buddy, a physical therapist in training, supervises 13 of
the 42 sessions. Primary goals of the buddy are to keep partic-
ipants motivated for adherence to the program and to assure
safety of the program. Supervised sessions are frequent in
the beginning of the intervention period and become less
frequent during the course of the program. On the first day
of the exercise program, the buddy informs the participant
about the program (e.g., importance ofwarming up and cooling
down, instructions about safe exercising [prevention of injuries
and use of appropriate clothing]). The provided bicycle ergom-
eter records training sessions to control adherence. Also, infor-
mation on adherence is recorded by the participant and buddy
using a diary. Participants monitor the intensity of each session
using the Borg Rating of Perceived Exertion [31] to rate the
amount of effort. Furthermore, participants record their ordi-
nary daily physical activities.3.2. Control group
Participants in the control group receive two individual
information sessions of 45 minutes in a period of 14 weeks.
The information sessions cover information about VCI and
cardiovascular risk factors. To control for the level of phys-
ical activity, participants in the control group are asked to re-
cord their physical activities in a diary. In addition, the
control group receives usual care, which comprises planned
outpatient visits (usually every 6 months, so one or none
within the study period).
To strengthen recruitment and adherence to the program,
participants in the control group are provided with a bicycle
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Fig. 2. 4! 4 minutes aerobic interval training model.
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introduction to aerobic exercise and encouragement to
participate in sport activities.4. Measures
4.1. Primary outcome measure
CBF is measured with ASL-MRI, a quantitative and
noninvasive technique to measure CBF by using magneti-
cally labeled arterial blood protons as endogenous tracer.
TheMRI protocol consists of two ASL-sequences: (1) perfu-
sion imaging (pseudocontinuous ASL [pCASL]) to quantify
CBF, and (2) multiphase pCASL with multiple postlabel
delay acquisitions to measure arterial transit time. Transit
time is the duration for the magnetically labeled arterial
blood water to travel from the labeling region in the neck
region to the tissue of interest. Transit time varies across
the brain and is dependent on the arterial size, stiffness,Table 3
Standardized neuropsychological assessment and measures of daily functioning n
Test/questionnaire Domain(s)
Cognitive functioning
Mini-Mental State Examination Global cog
15-Word-Auditory Verbal Learning Test (AVLT)* Episodic m
Visual Association Test, short version Implicit ass
Digit-Span of the WAIS-III (forward and backward) Working m
Fluency, 60 s (animals) Verbal wor
Letter Digit Substitution Test, 90 s Information
Stroop Color Word Test Information
Trail Making Test (part A and B) Information
Daily functioning, neuropsychiatry, and quality of life
Clinical Dementia Rating Global ratin
Amsterdam instrumental activities in daily life Activities o
Disability Assessment of Dementia Activities o
15-item Geriatric Depression Scale Depressive
Starkstein Apathy Scale [36] Apathy sym
EuroQol-5D, including EuroQol Visual Analog Scale [37] Health-rela
Short Stroke-Specific Quality of Life Scale [38] Quality of l
*To minimize test and retest effect, a parallel version of the 15-Word-AVLT isand the cardiac output fraction [32,33]. The influence of
transit time is of particular interest in patients with altered
hemodynamic status, for example, in patients with VCI.
Moreover, the estimation of transit time aids in improving
CBF quantification by means of pCASL. Furthermore, to
correct for possible confounders on ASL-MRI, participants
are instructed to refrain from alcohol during 24 hours before
the MRI, from caffeine and smoking during the preceding
6 hours, and from eating 1 hour before the MRI measure-
ments.
4.2. Secondary outcome measures4.2.1. Cognitive functioning, (instrumental) activities of
daily living, and quality of life
In this project, we use the standardized comprehensive test
battery that has been developed in context of theDutch Parels-
noer Initiative [34] and is designed to cover global cognitiveeuropsychiatry and quality of life [35]
nition
emory
ociative visual learning
emory
d fluency/semantic memory
processing speed
processing speed, attention, and response inhibition/executive functioning
processing speed, attention, and concept shifting/executive functioning
g of dementia severity
f daily life
f daily life
symptoms
ptoms
ted quality of life
ife in patients with stroke
administered at the postassessment.
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attention, language, and executive functioning (Table 3).
Furthermore, we assess general functioning and instrumental
activities of daily living necessary to establish a diagnosis of
dementia. We use validated scales of depressive symptoms,
apathy, and quality of life.
4.2.2. Physical fitness and physical activity
Cardiorespiratory fitness is assessed by a maximum
capacity test (maximal oxygen consumption [VO2max test])
on an electromagnetic bicycle ergometer. Work rate is
progressively increased with 10, 15, 20, or 25 W per minute
during an individualized cycle ergometer ramp protocol. The
protocol is based on the estimated physical capacity of the
participants (i.e., for deconditioned individuals an increment
of 10 W per minute, for conditioned individuals 20 W per
minute). Stopping criteria for the VO2max test, as recommen-
ded by the American College of Sports Medicine, were
physical exhaustion, rounds per minute ,60, or safety rea-
sons [39]. HR recordings (12-lead electrocardiogram) and
gas exchange measurements (breath-by-breath gas analysis;
Quark CPET, COSMED SRl, Rome, Italy) are recorded
throughout the test, and blood pressure is measured every
3 minutes. In addition, participants perform a 6-minute
walk test (6MWT) [40]. Both after the VO2max test as after
the 6MWT, participants are asked to monitor the intensity
using Borg’s Rating of Perceived Exertion. Amount, fre-
quency, and intensity of physical activity in daily life are
monitored by a triaxial activity monitor (ActiGraph
GT3X1, ActiGraph, Pensacola, FL), which is worn for
seven consecutive days after screening and postassessment.
The Physical Activity Scale in the Elderly is used to estimate
the participants’ physical activity in daily life [41]. This
self-report questionnaire is a valid measure of physical
activity in older individuals.
4.2.3. Blood biomarkers
We investigate both systemic and organ-specific bio-
markers in blood that relate to functional or structural abnor-
malities in one or more of the components of the heart-brain
axis and might be influenced by the intervention. For the
systemic biomarkers, we focus on biomarkers linked to
processes that are involved in heart failure, atherosclerosis,
and VCI, in particular, abnormalities in lipid metabolism,
insulin resistance/dysglycemia (i.e., glucose, insulin, and
HbA1c), and inflammation (i.e., plasma C-reactive protein,
fibrinogen, interleukin (IL)-1, IL-6, IL-10, soluble growth
stimulation expressed gene 2 (s-ST2), and tumor necrosis
factor a) and anemia (i.e., hemoglobin). For organ-specific
biomarkers (i.e., markers that reflect pathogenic processes
in organ-specific components of the heart-blood vessels-
brain axis), we assess markers of heart failure and cardiac
fibrosis (i.e., serum NT-proBNP, high-sensitivity TnT,
galectin-3, and serum creatinine) and remodeling of blood
vessel pathology (i.e., plasma homocysteine and endostatin)
and of Alzheimer-type pathology (i.e., plasma Ab40 andAb42). Finally, we consider biomarkers that are specifically
involved in potential other mechanisms of the effect of
the intervention on cognition (i.e., brain-derived neurotro-
phic factor, insulin-like growth factor 1 and vascular
endothelial growth factor, and thyroid-stimulating hormone)
[42]. Blood samples were collected in a nonfasting state.
Participants are requested to provide informed consent for
DNA storage for genetic analyses within the scope of the
current research project (i.e., apolipoprotein E polymor-
phism [APOE] genotype) and currently unknown genetic
variants that might be involved in risk of cardiovascular
disease and/or cognitive decline.
4.2.4. Brain structure
Brain and cardiac (see subsequently) MRI is acquired on
a Philips Gemini 3 T PET-MR scanner in the VUmc and a
Philips Ingenia 3 T scanner in the UMCU (Philips Health-
care Europe, Best, the Netherlands). Scans are screened by
local radiologists for the occurrence of clinically relevant
findings; visual ratings will be applied to characterize cere-
brovascular involvement. The brain protocol includes,
besides two ASL sequences (see primary outcome measure),
T1-weighted, fluid attenuated inversion recovery, and sus-
ceptibility weighted imaging images. The quantitative imag-
ing biomarkers from the brain MRI are computed with
existing software and software that is specifically designed
for the Heart-Brain Connection and for ExCersion-VCI.
Brain MRIs are processed with two automated pipelines
resulting in the following biomarkers: (1) volumes in milli-
liters (mL) of total brain GM, WM, cerebrospinal fluid, and
white matter hyperintensities, and (2) total brain volume,
GM volume, and WM volume of 83 structural brain regions
(mL; obtained using atlas-based segmentation with Ham-
mer’s atlas).
4.2.5. Cerebral autoregulation and cerebral vasomotor
reactivity (add-on study)
All participants are invited to participate in an add-on
study. We assess dynamic CA and CVMR at baseline and
postassessment. Dynamic CA is quantified in the frequency
domain as the counter-regulatory capacity to maintain CBF
velocity (CBFv; transcranial Doppler ultrasonography)
during spontaneous oscillations in blood pressure (finger
plethysmography) [43]. Both CBFv and blood pressure are
continuously measured in the supine and standing position
of the participant.
CVMR is quantified by noninvasive and continuous mea-
surements of CBFv and end-tidal CO2 (using a nasal
cannula) during hyperventilation, normal breathing, and
normal breathing when inhaling a gas mixture containing
5% CO2 and 95% O2 (i.e., carbogen). We perform an addi-
tional bicycle test to quantify the increase in CBFv in
response to sympathetic stimulation. The work rate is
progressively increased in a similar manner as during the
protocol that measures VO2max, until 70% of maximal HR
has been reached.
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Data on risk factors for VCI and relevant comorbidities
are collected according to the framework of the recent
American Heart Association position statement on VCI
[44]. Nonmodifiable risk factors include demographic
factors (gender, age, and ethnicity). Modifiable risk fac-
tors include lifestyle factors (education, physical activity,
alcohol use, and smoking), depression, current medication
use, and cardiovascular risk factors (including blood
pressure, body mass index and waist-hip ratio, markers
of glucose, and lipid metabolism).
4.3.2. Cardiac MRI
Cardiac MRI is performed at baseline with electrocar-
diographic gating and a phased array cardiac receiver
coil. Cine images in two-chamber left, two-chamber
right, three-chamber, four-chamber, and short-axis views
are obtained using a balanced steady-state free precession
pulse sequence in breath-hold. Anatomy and dimensions
of the thoracic aorta are visualized using a balanced
steady-state free precession pulse sequence. Free breath-
ing two-dimensional through-plane velocity-encoded
flow imaging is performed to measure mitral inflow and
ascending/descending aorta flow at the level of the pul-
monary trunk. The following parameters are determined:
dimensions and function of the atria and ventricles, left
ventricular ejection fraction, cardiac output, left ventric-
ular mass, diastolic dysfunction (E/A ratio mitral inflow),
left atrial volume, valve abnormalities, and aortic pulse
wave velocity.
4.3.3. Transthoracic echocardiography
All participants included in the VUmc undergo transtho-
racic ultrasound echocardiography. This assessment in-
cludes systolic and diastolic ventricular function both left
and right sided, atrial and ventricular dimensions and valve
function. Echocardiography is performed in standard para-
sternal, apical, and subcostal views and is noninvasive,
harmless, and routinely used in cardiac patients.5. Statistical methods
5.1. Sample size
The primary outcome measure is change in CBF after
14 weeks. To our knowledge, no former study has inves-
tigated the effect of aerobic exercise on CBF in patients
with VCI. In a Cochrane review, evaluating 11 RCTs
comparing aerobic exercise training with any other or
no intervention in healthy participants older than 55 years,
it was concluded that aerobic exercise training is benefi-
cial for cognitive functioning [7]. A large effect size
on cognitive functioning was found on attention (mean
summary effect size of 0.50), a moderate effect sizewas observed for cognitive speed (mean summary effect
size of 0.26). Studies in this review used the same neuro-
psychological tests as in the present study. In this study,
we focus on the underlying mechanism of aerobic exer-
cise on cognitive functioning. Assuming that aerobic ex-
ercise exerts its effect on cognition through an improved
CBF, we suspect that the effect size on CBF is larger.
On the basis of the studies focusing on CBF in patients
with dementia [45,46], we assume a large effect size of
0.60. This corresponds to a difference in (mean change
in CBF of 3 6 5 mL/100 mg/min), as was found
in a longitudinal study of patients with hypertension,
compared with patients without hypertension [46]. Pre-
liminary calculations suggest that for an effect size of
0.6, a total number of 74 patients randomized 1:1 to the
intervention and control group (N 5 37 in each group)
is needed to detect an effect of aerobic exercise on CBF
with a significance level of 0.05 and statistical power of
80%. To correct for potential dropout, 40 patients are
enrolled in each arm.5.2. Data analysis
Statistical analyses of the outcome parameters are
performed using intention-to-treat analyses. In addition, a
per-protocol analysis is performed to investigate the biolog-
ical effect of physical activity.
Analysis of variance for repeated measures is used
to examine an effect of the intervention with intervention
as between-groups-variable and time as within-groups-
variable; age, sex, and measures of small vessel disease
(white matter hyperintensities and lacunes) are entered as
covariates. CBF is the dependent variable, in additional
models the secondary outcome measures (i.e., cognition,
structural MRI, physical fitness, blood biomarkers) are
used as dependent variables.
Effect modification of cardiac output is examined using
interaction terms between randomization group (interven-
tion vs. control group) and cardiac output. The rationale
for this analysis is that we expect higher cardiac output
to affect the magnitude of response to aerobic exercise.
Stratified analysis (high vs. low cardiac output) is performed
when there is a significant interaction (P , .10). The signif-
icance level for the analyses of the outcome variables is set
at ,.05.6. Discussion
ExCersion-VCI is part of the Heart-Brain Connection, a
national interdisciplinary collaborative network [25]. In
this consortium, we aim to give insight into the relationships
between cardiovascular and hemodynamic factors and brain
structure and cognitive functioning in VCI. The Heart-Brain
Connection is a unique multidisciplinary collaboration
including neurologists, cardiologists, neuropsychologists,
radiologists, and MR-physicists.
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which aims to investigate the effect of aerobic exercise
on CBF in VCI patients. This study is a multicenter
single-blind RCT. Patients are randomized in an aerobic
exercise group or control group. Primary outcome mea-
sure is change in CBF as measured with ASL-MRI. Epide-
miologic studies indicate exercise as a contributor to
healthy brain aging with the potential to delay the onset
of cognitive impairment and dementia. Nevertheless,
questions about the intensity, duration, and frequency of
exercise remain. For instance, we do not know what the
most optimal and effective exercise program is for
different patient groups. Although the prevalence of
VCI and dementia increases, few RCTs of exercise have
been conducted in populations at high-risk for dementia.
Also, few RCTs have investigated primarily the potential
mechanism behind the effect of aerobic exercise on cogni-
tive functioning or investigated this mechanism in pa-
tients who are at risk for dementia. To emphasize the
potential of exercise in preventing or delaying dementia,
we need to understand the underlying mechanisms behind
the effect of exercise on cognitive functioning. Earlier
findings suggest that exercise sets into motion an
improvement in brain structure and function because of
modulation of vascular risk factors, increase in growth
factors, stimulation of neurogenesis, angiogenesis, and
enhancement of growth and protection of neurovascula-
ture, which could lead to an improvement in CBF
[16,47–49]. ExCersion-VCI is an important step in quan-
tifying a possible improvement of CBF, which can lead to
improved cognitive functioning in VCI patients. Aerobic
exercise, if effective, represents an affordable and acces-
sible method in halting and may be even preventing
ongoing cognitive decline ultimately progressing to de-
mentia in patients with VCI.Acknowledgments
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1. Systematic review: We performed a literature search
using PubMed regarding the mechanism behind the
effect of aerobic exercise on cognition.
2. Interpretation: Exercise programs aiming at
improvement of physical fitness have shown benefi-
cial effects on cognition in healthy elderly individ-
uals, but whether it will provide such effects in
cognitively impaired patients is uncertain. Further-
more, aerobic exercise has been found to reduce
the risk of stroke, suggesting that the beneficial effect
of aerobic exercise on cognition is secondary to an
increase in cerebral blood flow.
3. Future directions: In this study we hypothesize that
aerobic exercise will have a positive effect on cere-
bral blood flow in patients with VCI. We expect ex-
ercise on cerebral perfusion in patients with VCI to
provide further insight into the potential of aerobic
exercise to improve hemodynamic status and hence
improve cognitive functioning in patients with VCI.References
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